Editorial
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Surg. Apr 27, 2025; 17(4): 102487
Published online Apr 27, 2025. doi: 10.4240/wjgs.v17.i4.102487
Brief insight regarding the use of transanal, laparoscopic, and robotic total mesorectal excision for rectal cancer
Kevan English
Kevan English, Department of Medicine, University of Nebraska Medical Center College of Medicine, Omaha, NE 68198, United States
Author contributions: English K wrote the original draft, contributed to conceptualization, writing, reviewing, and editing; The author has read and approved the final version of the manuscript.
Conflict-of-interest statement: The author reports no relevant conflict of interest for this article.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Kevan English, MD, Associate Chief Physician, Department of Medicine, University of Nebraska Medical Center College of Medicine, S 42nd & Emile St, Omaha, NE 68198, United States. keenglish@unmc.edu
Received: October 21, 2024
Revised: January 18, 2025
Accepted: February 14, 2025
Published online: April 27, 2025
Processing time: 161 Days and 2.6 Hours
Core Tip

Core Tip: Total mesorectal excision (TME) is the standard of treatment for patients with low/mid locally advanced rectal cancer. This article compares the three minimally invasive surgical approaches (robotic, transanal, and laparoscopic TME) and their comparative efficacy relative to each other using the existing data in the literature.